Oruka Therapeutics (ORKA) 10-K2007 FY Annual report

Filed: 12 Mar 08, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: acquiree, Add, Addendum, Amex, AML, analogy, Angiomax, antagonizing, Appendix, auction, authoritative, Bendekgey, bivalirudin, blast, bone, bore, Borrowing, chimeric, chronic, CLL, Composite, conclusion, County, cytotoxic, debilitating, delinquency, demurrer, differentiation, disability, domain, downgrade, entirety, exciting, excused, Exposition, extra, family, fiduciary, fifty, frequently, Frizzled, FSP, genomic, GI, graph, Greta, ground, healing, heard, Hematology, home, husband, IBD, indirectly, largest, Lee, leukemia, lump, lymphocytic, lymphoid, lymphoma, mAb, Marshall, Mateo, modulate, myeloid, myeloma, Neurologic, nonfinancial, observed, opportunity, opposition, osteolytic, paired, palifermin, passed, pathway, peptic, Pharma, pose, prejudice, prioritization, Programme, rational, reacquire, realign, realigning, receptor, recommenced, reconciliation, recurring, regeneration, rehire, remodeling, reply, representation, residential, rework, RSpo, shift, Society, statute, streamlined, streamlining, strict, subprime, subtenant, top, undiscounted, unfavorable, unoccupied, unpaid, unrecognized, Variation, weighed, Wnt, wound, xenograft

Removed: absorbed, accelerate, accrue, ACS, AMB, angina, angioplasty, anticoagulation, approving, Arch, assigned, atherosclerotic, attack, averse, barry, bear, bearing, blocking, bloodstream, body, capability, care, carry, central, chip, clinically, clotting, collect, comprised, conclude, considerably, consisting, Consultant, conversion, Cyanamid, deep, deficiency, depleted, depreciated, designation, discontinued, disposed, distant, division, driven, earn, elevation, ending, equally, estimable, exceeded, exceeding, executed, exert, exist, favor, fewer, fractional, generation, heart, hemorrhage, hiring, hospital, inappropriate, incidence, increasingly, indefinite, infarction, infection, influence, initiating, instituting, intensive, issuer, leading, limiting, locally, managed, Medicare, mitigated, Modernization, monetize, multiplying, muscle, mutual, myocardial, negotiated, nematode, orphan, overlapping, owed, owner, oxygen, paper, par, payer, Perfusion, pharmacy, plaque, Pledge, precluded, Prescription, preservation, profitable, project, protease, qualify, randomized, rare, ratio, recurrent, reinvestment, reliably, repay, repayment, resolved, retired, retroactively, secondary, sequencing, shipped, showed, stay, syndrome, TIMI, treating, trend, underwritten, universal, unnecessary, unstable, varied, vascular, zubrow

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

ORKA similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the registration statements on Form S-3 (Nos. 333-148288, 333-131392, 333-128316, 333-126591, 333-118821, 333-112209, 333-106873, 333-103257, 333-90458 and 333-70134) and the registration statements on Form S-8 (Nos. 333-146078, 333-134981, 333-126590, 333-115747, 333-108563, 333-103055, 333-101276, 333-96313, 333-91471, 333-68172, 333-68170, 333-53089, 333-53087, 333-41663, 333-39194 and 333-08978) of Nuvelo, Inc. of our reports dated March 11, 2008, with respect to the consolidated financial statements of Nuvelo, Inc., and the effectiveness of internal control over financial reporting of Nuvelo, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2007.

/s/ Ernst & Young LLP

Palo Alto, California

March 11, 2008